
Scientific literature is a significant source of information for the monitoring of the safety profile of medicinal products, particularly in relation to the detection of new safety signals or emerging safety issues.
With global regulations constantly shifting and with the level of scientific literature progressively increasing, pharmacovigilance teams are under continued pressure to create literature strategies that are both comprehensive and flexible. Therefore, establishing the right process from the outset is fundamental to ensure that compliance deliverables are met.
